Venture • Life Science

EW Healthcare Partners Invests In Molecular Partners

On December 15, 2009, growth capital firm EW Healthcare Partners invested in life science company Molecular Partners

Investment Context
  • This is EW Healthcare Partners’ 13th transaction in the Life Science sector.
  • This is EW Healthcare Partners’ 1st transaction in Switzerland.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date December 15, 2009
Target Molecular Partners
Sector Life Science
Investor(s) EW Healthcare Partners
Deal Type Venture

Target Company

Molecular Partners

Schlieren, Switzerland
Molecular Partners is a clinical-stage biotech company developing DARP in therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. Molecular Partners was founded in 2004 and is headquartered in Schlieren, Switzerland.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

EW Healthcare Partners

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1985
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.


Deal Context for Investor #
Overall 36 of 59
Sector: Life Science 13 of 20
Type: Venture 26 of 32
Country: Switzerland 1 of 1
Year: 2009 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-12-08 ikaSystems

Southborough, Massachusetts, United States

ikaSystems Corp. is a provider of integrated online software applications to the healthcare payer industry.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-01-04 BioForm Medical

San Mateo, California, United States

Bioform Medical is a medical device company introducing a family of proprietary, injectable implant products used in minimally invasive soft tissue augmentation procedures. BioForm Medical is based in San Mateo, California.

Sell $253M

Explore Related M&A Activity